MEI Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
MEI Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2023.
  • MEI Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2023 was $76.2M, a 10.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $76.2M +$7.02M +10.1% Jun 30, 2023 10-K 2023-09-26
Q2 2022 $69.2M +$15.5M +28.8% Jun 30, 2022 10-K 2023-09-26
Q2 2021 $53.7M +$10.5M +24.4% Jun 30, 2021 10-K 2022-09-08
Q2 2020 $43.2M +$4.48M +11.6% Jun 30, 2020 10-K/A 2022-05-23
Q2 2019 $38.7M +$9.08M +30.7% Jun 30, 2019 10-K 2020-09-09
Q2 2018 $29.6M -$14.9M -33.5% Jun 30, 2018 10-K 2019-08-28
Q2 2017 $44.5M -$27.7M -38.3% Jun 30, 2017 10-K 2018-08-30
Q2 2016 $72.2M +$7.95M +12.4% Jun 30, 2016 10-K 2017-09-05
Q2 2015 $64.2M +$12.5M +24.3% Jun 30, 2015 10-K 2016-09-06
Q2 2014 $51.7M +$10.8M +26.4% Jun 30, 2014 10-K 2015-09-02
Q2 2013 $40.9M +$4.45M +12.2% Jun 30, 2013 10-K 2014-09-09
Q2 2012 $36.4M -$27.2M -42.8% Jun 30, 2012 10-K 2013-09-18
Q2 2011 $63.6M Jun 30, 2011 10-K 2012-09-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.